Keloid

Dermatology·MeSH: Keloid

8 drugs in development·3 companies·3 clinical trials

Drug Pipeline by Phase

Approved(3)

Phase 2(1)

Drug	Company
Vehicle	Revance Therapeutics, Inc. (RVNC)

N/A(1)

Drug	Company
Verapamil Hydrochloride	Clearside Biomedical, Inc. (CLSDQ)

Phase 4(3)

Drug	Company
Botulinum toxin type A	Revance Therapeutics, Inc. (RVNC)
Botulinum Toxin Type A 100U	Revance Therapeutics, Inc. (RVNC)
Botulinum Toxin Type A 200U	Revance Therapeutics, Inc. (RVNC)

BioSniper tracks 8 drugs in development for Keloid across 3 companies.

There are 3 clinical trials targeting Keloid tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.